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Natural bioenhancers reported to improve bioavailability and bioefficacy in combination therapy. Many studies are increasingly showing interest toward 
the improvement of bioavailability of a large number of synthetic and herbal drugs by natural bioenhancers.  In modern medicine treatment cost and 
adverse effect are major concern, hence systematic innovative means to reduce treatment cost and adverse effect are needed. Natural compounds such 
as resveratrol, piperine, glycyrrhizine, quercetin, sinomenine and Cumins demonstrated capability to enhance bioavailability. The objective of this 
review is to summarize upto date information of natural bioenhancers. 
 





According to the Code of Federal Regulations, bioavailability is 
the rate and extent to which the active drug ingredient or 
therapeutic moiety is absorbed from a drug product and becomes 
available at the site of drug action.1 A natural bioenhancer is an 
agent of herbal origin or any phytomolecule, which is capable of 
enhancing bioavailability and bioefficacy of a particular drug or 
nutrient with which it is combined, without any typical 
pharmacological activity of its own at the dose used. They tend to 
decrease the dose of active drug required for the optimal endpoint 
of the treatment strategy.2 Oral bioavailability depends on a 
number of factors, primarily drug permeability, aqueous 
solubility, dissolution rate, presystemic metabolism, first-pass 
metabolism and susceptibility to efflux mechanisms. Among 
these factors low permeability and poor solubility stands as the 
most frequent causes of low oral bioavailability.3 The 
bioavailability and bioefficacy of some drugs may be enhanced 
by food, for example, an acid environment is necessary for the 
absorption of ketoconazole and absorption of griseofulvin is 
increased by high fat diet. Fenofibrate, mebendazole, isotretinoin, 
tamsulosin, carbamazepine and labetalol are some examples of 
drugs that show better absorption while taken with food.4, 5 Food, 
dietary supplements and their components can have impact on the 
achievement of drug action and on the side effect profiles of 
various drugs. Upon entry into the stomach, food may alter the 
rate or the extent of drug absorption through a variety of direct 
and indirect mechanism. The interactions are not always 
detrimental to therapy, but in some cases can be used to improve 
drug absorption or to minimize adverse effects. These interactions 
have received more interest recently.6 
 
Polyphenols such as anthocyanins, coumarins, flavonoids, 
lignans and tannins present in herbs, vegetables, fruits, flowers, 
and leaves in many plants, are believed to be beneficial to human 
health by exerting biological effects such as free radical 
scavenging.7-9 Most dietary flavonoids present in food exist as O-
glycosides with glucose, glucorhamnose, galactose, arabinose, or 
rhamnose.10 The β-linkage of these glycosides resist hydrolysis 
caused by acidity in the stomach and the attack by pancreatic 
enzymes. However, β-endoglucosidases present in small intestine 
are able to hydrolyse flavonoid glycosides.11 Additionally, 
colonic microflora hydrolyses the sugar moiety from the 
flavonoid aglycone, thus increasing the absorption of flavonoids. 
During absorption, the flavonoids may interact with metabolising 
enzymes and transport proteins, and thus affect the uptake of co-
administered drugs. Indeed, polyphenols are potent inhibitors or 
inducers of CYPs, UGTs and transport proteins, if consumed in 
large amounts.12-14 However, only few studies on herbal 
bioenhancers has been reported.2, 15 Hence, the present review 
aims to compile a comprehensive up-to-date information on the 
progress made on natural bioenhancers. 
 
MECHANISMS OF ACTION OF NATURAL 
BIOENHANCERS  
 
There are several mechanisms of action by which herbal 
bioenhancers work. Among the various mechanism of action 
postulated for natural bioenhancers some are P-gp inhibition 
activity, reduction in acid secretion, increase in gastrointestinal 
blood supply, inhibition of of gastrointestinal transit, gastric 
emptying, inncrease in intestinal motality, modifications in GIT 
epithelial cell membrane permiability and inhibition of first pass 
metabolism and metabolizing enzymess.2, 15 Flavone, quercetin 
and genistein have showed a considerable P-gp inhibition 
activities. Additionally, naringin and sinomenine were also 
reported to be inhibitors for efflux transporters such as P-gp and 
breast cancer resistance protein.16, 17 Many natural compounds are 
effective in improving the intestinal absorption of other drugs and 
neutrients, example of such agents are: bile salts, surfactants, fatty 
acids, chelating agents, salicylates and polymers. These 
surfactants act as bioenhancers by increasing the solubility of 
hydrophobic drugs in the aqueous layer or by increasing the 
fluidity of the apical and basolateral membranes.18, 19 
Trimethylated chitosan increase drug absorption by redistribution 
of the cytoskeletal F-actin, causing the opening of the tight 
junctions.20 
 




Resveratrol (3,4′,5- trihydroxystilbene) is a nutraceutical that has 




pharmacological potential. It is a phytoalexin found in many 
plants including red wine, grapes, peanuts, and berries.3 Co-
administration of apigenin and resveratrol led to a 2.39 fold 
increase in plasma apigenin levels compared to administration of 
apigenin alone. Resveratrol inhibites the formation of apigenin 







Piperine is a major alkaloidal component of Piper nigrum Linn. 
(Piperaceae). Piperine, or mixtures containing piperine, has been 
shown to increase the bioavailability, blood levels and efficacy of 
a number of drugs including vasicine, sparteine, sulfadiazine, 
rifampicin, phenytoin and propranolol.22, 23 Piperine act by 
suppressing P-gp and cytochrome P450 enzymes, which 
counteract the metabolism of rifampicin via these proteins, thus 
enhancing the oral bioavailability of rifampicin. It also decreases 
the intestinal production of glucuronic acid, thus allowing more 
substances to enter the body in active form. It was found to 




Black Cumin  
 
Nigella sativa (Black cumin) belonging to family Ranunculaceae. 
It is extensively used in the Indian diasporas as spice, which may 
interact with co-administered drugs and affect their intestinal 
availability. In the in-vitro study methanolic and hexane extracts 
of Nigella increased the permeation of amoxicillin significantly. 
In in-vivo experiments black cumin enhanced amoxicillin 
bioavailability. Cmax of amoxicillin increased in rat plasma when 
administered orally alone and in combination with hexane extract 
correspondingly from 4138.25±156.93 to 5995.04±196.28 ng/ml 








Glycyrrhizin is a triterpenoid saponin found in Glycyrrhiza 
glabra Linn. (Leguminosae). The absorption-enhancing activity 
of sodium deoxycholate and dipotassium-glycyrrhizinate was 
much greater when coadministered with glycyrrhizin. The 
absorption enhancing activity of glycyrrhizin was increased by 
presence of other absorption enhancers.25 Glycyrrhizin showed a 
more potent absorption enhancing activity than caproic acid at the 







Cuminum cyminum Linn. (Apiaceae) is an annual herb, its fruits 
are generally used as spice. Cumin oils and its bioactive 
compound like luteolin seemed to attribute the bioavailability 
enhancing activity. Luteolin has been reported to be a potent P-
gp inhibitor.27 Bioavailability enhancing activity of C. cyminum 

























































Genistein, well known as a phytoestrogen29 inhibits P-gp, Breast 
Cancer Resistance Protein (BCRP)  and Multidrug Resistance-
Associated Protein 2 (MRP2) efflux function. The intestinal 
absorption of paclitaxel, a substrate for efflux transports such as 
P-gp, BCRP and MRP2 considerably increased when co-
administered with genistein. It has been reported that the 
inhibition of the efflux transporters by genistein improve 






Naringin is the major flavonoid glycoside found in grapefruits, 
that shows the inhibition of P-gp and CYP3A in rats.31 Area under 
curve (AUC) of paclitaxel is increased significantly in presence 






Sinomenine, an alkaloid extracted from Sinomenium acutum 
(Menispermaceae). Paeoniflorin, bioactive monoterpene 
glucoside has a poor bioavailability (3-4%) when administered 
orally.33 Co-administration of paeoniflorin with sinomenine, the 
AUC of paeoniflorin significantly increased, thus the oral 
bioavailability of paeoniflorin was enhanced by more than 12 






Quercetin is a flavonoid found in Citrus fruits. It is reported that 
quercetin increase bioavailability, blood levels and efficacy of a 
number of drugs such as diltiazem,35 digoxin36 and 
epigallocatechin gallate.37 The absorption of epigallocatechin 
gallate has been enhanced with red onion supplementation, which 
is a rich source of quercetin. The AUC of epigallocatechin gallate 
determined over a period of 6 h increased from 1323 to 1814 






Peppermint oil extracted from Mentha species contains mainly 
menthol and menthone. Co-administration of cyclosporine and 
Peppermint oil, it increased cyclosporine maximum concentration 
(Cmax) and  area under the concentration versus time curve (AUC0-
a) from 0.60 to 1.6 µg/ml and 8.3 to 24.3 µg.h/ml, respectively in 






Nitrile glycosides and its derivatives such as niazirin and 
niaziridin is obtained from the leaves, pods, and bark of Moringa 
oleifera (Moringaceae). These glycosides enhanced the 
absorption of commonly used antibiotics such as rifampicin, 






Zingiber officinale (Zingiberaceae) is one of the components of 
Trikatu which also possess significant bioavailability 





















































gingerol and shagol. Gingerols and shagols are responsible for 
pungency of Ginger. It has a powerful effect on mucous 
membrane of the gastrointestinal tract. It regulates the intestinal 
functions to facilitate absorption. Ginger when used in the dose 
of 10–30 mg/kg body weight acts as bioenhancer. 
Pharmacological studies shows that it dramatically enhanced the 
bioavailability of various medicines especially antibiotics such as 
amoxicillin, azithromycin, erythromycin, cephalexin, cefadroxil, 






Natural bioenhancers leads an innovative concept in the drug 
discovery. They will lead to reductions in drug cost, toxicity, 
adverse effects and enhances therapeutic efficacy or bioefficacy. 
Research aimed at developing novel and powerful bioenhancers 
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